Annual Accounts Receivable
$46.00 K
+$10.00 K+27.78%
31 December 2023
Summary:
Titan Pharmaceuticals annual accounts receivable is currently $46.00 thousand, with the most recent change of +$10.00 thousand (+27.78%) on 31 December 2023. During the last 3 years, it has fallen by -$838.00 thousand (-94.80%). TTNP annual accounts receivable is now -98.72% below its all-time high of $3.59 million, reached on 31 December 2016.TTNP Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Receivable
$38.00 K
-$96.00 K-71.64%
30 June 2024
Summary:
Titan Pharmaceuticals quarterly accounts receivable is currently $38.00 thousand, with the most recent change of -$96.00 thousand (-71.64%) on 30 June 2024. Over the past year, it has increased by +$12.00 thousand (+46.15%). TTNP quarterly accounts receivable is now -99.31% below its all-time high of $5.51 million, reached on 31 March 2010.TTNP Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTNP Accounts Receivable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +27.8% | +46.1% |
| 3 y3 years | -94.8% | -85.7% |
| 5 y5 years | -97.3% | -95.1% |
TTNP Accounts Receivable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -94.8% | +27.8% | -85.7% | +375.0% |
| 5 y | 5 years | -97.3% | +27.8% | -97.5% | +375.0% |
| alltime | all time | -98.7% | +27.8% | -99.3% | +375.0% |
Titan Pharmaceuticals Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | - | $38.00 K(-71.6%) |
| Mar 2024 | - | $134.00 K(+191.3%) |
| Dec 2023 | $46.00 K(+27.8%) | $46.00 K(+76.9%) |
| Sept 2023 | - | $26.00 K(+188.9%) |
| June 2023 | - | $9000.00(+12.5%) |
| Mar 2023 | - | $8000.00(-77.8%) |
| Dec 2022 | $36.00 K(-67.9%) | $36.00 K(-26.5%) |
| Sept 2022 | - | $49.00 K(-51.5%) |
| June 2022 | - | $101.00 K(-53.7%) |
| Mar 2022 | - | $218.00 K(+94.6%) |
| Dec 2021 | $112.00 K(-87.3%) | $112.00 K(-57.7%) |
| Sept 2021 | - | $265.00 K(+157.3%) |
| June 2021 | - | $103.00 K(-74.1%) |
| Mar 2021 | - | $398.00 K(-55.0%) |
| Dec 2020 | $884.00 K | $884.00 K(+109.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2020 | - | $423.00 K(-60.1%) |
| June 2020 | - | $1.06 M(-31.6%) |
| Mar 2020 | - | $1.55 M(+254.1%) |
| Dec 2019 | $438.00 K(-74.8%) | $438.00 K(-43.5%) |
| Sept 2019 | - | $775.00 K(-32.0%) |
| June 2019 | - | $1.14 M(-44.4%) |
| Mar 2019 | - | $2.05 M(+18.1%) |
| Dec 2018 | $1.74 M(+2572.3%) | $1.74 M(+154.7%) |
| Sept 2018 | - | $682.00 K(+260.8%) |
| June 2018 | - | $189.00 K(+190.8%) |
| Dec 2017 | $65.00 K(-98.2%) | $65.00 K(-98.2%) |
| Dec 2016 | $3.59 M | $3.59 M(+88.4%) |
| Sept 2010 | - | $1.90 M(+399.7%) |
| June 2010 | - | $381.00 K(-93.1%) |
| Mar 2010 | - | $5.51 M(+3346.3%) |
| Mar 2003 | - | $160.00 K |
FAQ
- What is Titan Pharmaceuticals annual accounts receivable?
- What is the all time high annual accounts receivable for Titan Pharmaceuticals?
- What is Titan Pharmaceuticals annual accounts receivable year-on-year change?
- What is Titan Pharmaceuticals quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Titan Pharmaceuticals?
- What is Titan Pharmaceuticals quarterly accounts receivable year-on-year change?
What is Titan Pharmaceuticals annual accounts receivable?
The current annual accounts receivable of TTNP is $46.00 K
What is the all time high annual accounts receivable for Titan Pharmaceuticals?
Titan Pharmaceuticals all-time high annual accounts receivable is $3.59 M
What is Titan Pharmaceuticals annual accounts receivable year-on-year change?
Over the past year, TTNP annual accounts receivable has changed by +$10.00 K (+27.78%)
What is Titan Pharmaceuticals quarterly accounts receivable?
The current quarterly accounts receivable of TTNP is $38.00 K
What is the all time high quarterly accounts receivable for Titan Pharmaceuticals?
Titan Pharmaceuticals all-time high quarterly accounts receivable is $5.51 M
What is Titan Pharmaceuticals quarterly accounts receivable year-on-year change?
Over the past year, TTNP quarterly accounts receivable has changed by +$12.00 K (+46.15%)